Search alternatives:
less decrease » teer decrease (Expand Search), levels decreased (Expand Search), largest decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
less decrease » teer decrease (Expand Search), levels decreased (Expand Search), largest decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
241
-
242
-
243
-
244
-
245
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
Published 2025Subjects: -
246
Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.
Published 2025Subjects: -
247
-
248
-
249
-
250
Prolonged starvation leads to a delay in cell cycle re-entry and decrease in H3K27ac in Vasa2+/Piwi1+ cells.
Published 2025“…During starvation (T<sub>5ds</sub>, T<sub>20ds</sub>), MFI levels of H3K27ac progressively decreased <b>(F)</b> while levels H3K27me3 did not change significantly <b>(G)</b>. …”
-
251
-
252
-
253
-
254
-
255
-
256
-
257
-
258
-
259
-
260
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”